In HNSCC, we found that CASP1 is upregulated in tumor tissues (Table S2, p < .01), and it seemed to be a bad prognostic biomarker (HR > 1), indicating CASP1 might be a tumor‐promoting gene in HNSCC. This evidence concerns the gene CASP1 and head and neck squamous cell carcinoma.